Abstract
Acinetobacter baumannii is currently considered a major clinical pathogen accountable for causing several nosocomial infections and hospital outbreaks all over the globe. A. baumannii is accountable for causing bloodstream infections, pneumonia, meningitis, wound infection, urinary tract infection, endocarditis, peritonitis, and keratitis especially in individuals with low immunity. The pathogen has been reported to exhibit resistance against broad classes of antibiotics including carbapenems, aminoglycoside, quinolones, tetracyclines, cephalosporins, and polymyxin. Various virulence mechanisms have been identified and proposed for the resistance of A. baumannii towards the different class of antibiotics including inactivation or alteration of antimicrobials, alteration in membrane proteins, efflux pumps system, changes in the drug target, and biofilm formation. Furthermore, the ability to acquire and express exogenous antibiotic resistance genes is another contributing factor in imparting drug resistance to the pathogen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Tsakris A (2014) Spread of carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86(4):260–266
Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A (2014) Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis 22:49–54
Almaghrabi MK, Joseph MRP, Assiry MM, Hamid ME (2018) Multidrug-resistant Acinetobacter baumannii: an emerging health threat in Aseer Region, Kingdom of Saudi Arabia. Can J Infect Dis Med Microbiol 2018:1
Almasaudi SB (2018) Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci 25(3):586–596
Antunes LC, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71(3):292–301
Ardehali SH, Azimi T, Fallah F, Owrang M, Aghamohammadi N, Azimi L (2019) Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii. New Microbes New Infect 30:100547
Asif M, Alvi IA, Rehman SU (2018) Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 11:1249–1260
Babapour E, Haddadi A, Mirnejad R, Angaji SA, Amirmozafari N (2016) Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pac J Trop Biomed 6(6):528–533
Badave GK, Kulkarni D (2015) Biofilm producing multidrug resistant Acinetobacter baumannii: an emerging challenge. J Clin Diagn Res 9(1):DC08–DC10
Balkhy HH, El-Saed A, Maghraby R, Al-Dorzi HM, Khan R, Rishu AH, Arabi YM (2014) Drug-resistant ventilator associated pneumonia in a tertiary care hospital in Saudi Arabia. Ann Thorac Med 9(2):104–111
Cai Y, Chai D, Wang R, Liang B, Bai N (2012) Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 67(7):1607–1615
Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD (2009) Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 34(1):25–28
Chen KJ, Hou CH, Sun MH, Lai CC, Sun CC, Hsiao CH (2008) Endophthalmitis caused by Acinetobacter baumannii: report of two cases. J Clin Microbiol 46(3):1148–1150
Chopra T, Marchaim D, Awali RA, Krishna A, Johnson P, Tansek R, Kaye KS (2013) Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother 57(12):6270–6275
Cisneros JM, Rodriguez-Bano J (2002) Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 8(11):687–693
Coyne S, Courvalin P, Perichon B (2011) Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 55(3):947–953
Doi Y, Murray GL, Peleg AY (2015) Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 36(1):85–98
Gokmen TG, Akcimen B, Kayar B, Marzi M, Koksal F (2016) The outbreak of Acinetobacter baumannii producing OXA-23 and OXA-51 type carbapenemases in a state hospital. J Exp Clin Med 33(3):157–161
Greene C, Vadlamudi G, Newton D, Foxman B, Xi C (2016) The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control 44(5):e65–e71
Harding CM, Hennon SW, Feldman MF (2018) Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 16(2):91–102
Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA (2017) Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev 30(1):1–22
Inchai J, Pothirat C, Bumroongkit C, Limsukon A, Khositsakulchai W, Liwsrisakun C (2015) Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. J Intensive Care 3:9
Jain M, Sharma A, Sen MK, Rani V, Gaind R, Suri JC (2019) Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Microb Pathog 128:75–81
Khorsi K, Messai Y, Hamidi M, Ammari H, Bakour R (2015) High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian Pac J Trop Med 8(6):438–446
Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL (2009) Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 9(4):245–255
Lagana P, Melcarne L, Delia S (2015) Acinetobacter baumannii and endocarditis, rare complication but important clinical relevance. Int J Cardiol 187:678–679
Lee K, Yong D, Jeong SH, Chong Y (2011) Multidrug-resistant Acinetobacter spp: increasingly problematic nosocomial pathogens. Yonsei Med J 52(6):879–891
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Lee SH (2017) Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 7:55
Lolans K, Rice TW, Munoz-Price LS, Quinn JP (2006) Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother 50(9):2941–2945
Manchanda V, Sanchaita S, Singh N (2010) Multidrug resistant acinetobacter. J Global Infect Dis 2(3):291–304
Maragakis LL, Perl TM (2008) Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46(8):1254–1263
Mesli E, Berrazeg M, Drissi M, Bekkhoucha SN, Rolain JM (2013) Prevalence of carbapenemase-encoding genes including New Delhi metallo-beta-lactamase in Acinetobacter species Algeria. Int J Infect Dis 17(9):e739–e743
Necati Hakyemez I, Kucukbayrak A, Tas T, Burcu Yikilgan A, Akkaya A, Yasayacak A, Akdeniz H (2013) Nosocomial Acinetobacter baumannii infections and changing antibiotic resistance. Pak J Med Sci 29(5):1245–1248
Oh YJ, Song SH, Baik SH, Lee HH, Han IM, Oh DH (2013) A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea. Korean J Intern Med 28(4):486–490
Pagano M, Martins AF, Barth AL (2016) Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii. Braz J Microbiol 47(4):785–792
Rezaee MA, Pajand O, Nahaei MR, Mahdian R, Aghazadeh M, Ghojazadeh M, Hojabri Z (2013) Prevalence of Ambler class A beta-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn Microbiol Infect Dis 76(3):330–334
Rogers AD, Deal C, Argent AC, Hudson DA, Rode H (2014) Ventilator associated pneumonia in major paediatric burns. Burns 40(6):1141–1148
Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067
Senkyrikova M, Husickova V, Chroma M, Sauer P, Bardon J, Kolar M (2013) Acinetobacter baumannii producing OXA-23 detected in the Czech Republic. SpringerPlus 2(1):296
Sharma A, Sharma R, Bhattacharyya T, Bhando T, Pathania R (2017) Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter-AbaF. J Antimicrob Chemother 72(1):68–74
Shoja S, Moosavian M, Rostami S, Farahani A, Peymani A, Ahmadi K, Ebrahimifard N (2017) Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries. J Chin Med Assoc 80(4):245–252
Singh H, Thangaraj P, Chakrabarti A (2013) Acinetobacter baumannii: a brief account of mechanisms of multidrug resistance and current and future therapeutic management. J Clin Diagn Res 7(11):2602–2605
Subashchandrabose S, Smith S, DeOrnellas V, Crepin S, Kole M, Zahdeh C, Mobley HL (2016) Acinetobacter baumannii genes required for bacterial survival during bloodstream infection. mSphere 1(1):e00013
Vila J, Marti S, Sanchez-Cespedes J (2007) Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 59(6):1210–1215
Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M (2008) Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 27(7):607–612
Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B (2017) Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev 30(1):409–447
Xu C, Bilya SR, Xu W (2019) adeABC efflux gene in Acinetobacter baumannii. New Microbes New Infect 30:100549
Zhang W, Wu YG, Qi XM, Dai H, Lu W, Zhao M (2014) Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases. Perit Dial Int 34(3):317–321
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Rajkumari, J., Siddhardha, B. (2020). Acinetobacter baumannii: Infections and Drug Resistance. In: Siddhardha, B., Dyavaiah, M., Syed, A. (eds) Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Springer, Singapore. https://doi.org/10.1007/978-981-15-1695-5_14
Download citation
DOI: https://doi.org/10.1007/978-981-15-1695-5_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1694-8
Online ISBN: 978-981-15-1695-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)